1712.1 – Level 2 sleep studies for the diagnosis and management of sleep disordered breathing in children and adolescents

New Medicare Benefits Schedule items.

Level 2 polysomnography is the measurement of sleep in the same way as polysomnography undertaken in an overnight sleep study in a sleep laboratory. However, the study is undertaken at home or another location that is not a sleep laboratory and there is not continuous monitoring of the signals by a sleep technician as occurs in laboratory sleep study. Instead, signals are recorded overnight and data is downloaded and analysed after the sleep study.

Type: Investigative technology

Sleep disordered breathing is common in children, with obstructive sleep apnoea the most prevalent. Obstructive sleep apnoea is a partial or complete closing of the airway during sleep that results in lower oxygen levels within the body, snoring, daytime sleepiness and other health problems. Potential causes of sleep disordered breathing in children include enlarged adenoids and tonsils, obesity, reduced muscle tone of the airway and abnormalities of airway shape or size.

The following consultation deadlines apply:

• Pre-PASC consultation deadline: Bypassing PASC
• Pre-MSAC consultation deadline: Friday 13 June 2025 11:59 pm AEST  

For other ways to provide input, see how to have your say.

We welcome input from everyone. We are especially keen to hear from those with lived experience of the health condition, service or technology the applications are addressing.

Find out more about consultation.

This application will be considered at the following meetings:

• PASC meeting: Bypassing PASC
• ESC meeting: Bypassing ESC
• MSAC meeting: 31 July - 1 August 2025

Find out more about our meetings.

The outcome of this application is pending.

Find out more about:

• the MSAC process
• application types
• application timelines.